ATE299182T1 - Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie - Google Patents

Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie

Info

Publication number
ATE299182T1
ATE299182T1 AT96943239T AT96943239T ATE299182T1 AT E299182 T1 ATE299182 T1 AT E299182T1 AT 96943239 T AT96943239 T AT 96943239T AT 96943239 T AT96943239 T AT 96943239T AT E299182 T1 ATE299182 T1 AT E299182T1
Authority
AT
Austria
Prior art keywords
polypeptides
vaccines
polynucleotides
chemotherapy
diagnostics
Prior art date
Application number
AT96943239T
Other languages
English (en)
Inventor
John Hermon-Taylor
Tim Doran
Douglas Millar
Mark Tizard
Mark Loughlin
Nazira Sumar
John Ford
Original Assignee
St Georges Hosp Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Georges Hosp Medical School filed Critical St Georges Hosp Medical School
Application granted granted Critical
Publication of ATE299182T1 publication Critical patent/ATE299182T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96943239T 1995-12-21 1996-12-23 Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie ATE299182T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526178.0A GB9526178D0 (en) 1995-12-21 1995-12-21 Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
PCT/GB1996/003221 WO1997023624A2 (en) 1995-12-21 1996-12-23 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy

Publications (1)

Publication Number Publication Date
ATE299182T1 true ATE299182T1 (de) 2005-07-15

Family

ID=10785831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943239T ATE299182T1 (de) 1995-12-21 1996-12-23 Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie

Country Status (7)

Country Link
US (3) US6156322A (de)
EP (1) EP0870032B1 (de)
AT (1) ATE299182T1 (de)
AU (1) AU735112B2 (de)
DE (1) DE69634918T2 (de)
GB (1) GB9526178D0 (de)
WO (1) WO1997023624A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526178D0 (en) * 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
GB9806093D0 (en) 1998-03-20 1998-05-20 Taylor John Hermon Diagnostics and vaccines for mycobacterial infections of animals and humans
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
US6638518B1 (en) 1999-02-22 2003-10-28 University Of Iowa Research Foundation Method for inhibiting inflammatory responses
BR0005598B1 (pt) * 1999-09-16 2013-03-19 mÉtodo para proteger uma planta crescendo contra insetos rastejantes.
WO2003018053A1 (en) * 2001-08-22 2003-03-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine against mycobacterial-induced diseases
MXPA04012137A (es) 2002-06-03 2005-09-21 E Click Robert Bacteriana novedosa para tratamiento de enfermedad.
DE102004013988A1 (de) * 2004-03-19 2005-10-13 Henkel Kgaa Der Faktor RecA aus Bacillus licheniformis und recA-inaktivierte Sicherheitsstämme für die biotechnologische Produktion
US7488580B1 (en) * 2005-03-10 2009-02-10 University Of Central Florida Research Foundation, Inc. Protocol for detection of Mycobacterium avium subspecies paratuberculosis in blood
WO2007017635A1 (en) * 2005-08-09 2007-02-15 St George's Enterprises Limited Immunogenic constructs
US8465753B2 (en) * 2007-04-23 2013-06-18 Robert J. Greenstein Combination vaccines against Mycobacterium sp. and methods of using the same
US7846420B2 (en) * 2007-04-23 2010-12-07 Greenstein Robert J Mycobacterium avium subspecies paratuberculosis vaccines and methods of using the same
EP2696891B1 (de) 2011-04-11 2019-06-26 Alarum Development Ltd Neue impfstoffe zur vorbeugung und behandlung von tuberkulose
GB201700487D0 (en) 2017-01-11 2017-02-22 Hermon-Taylor John Diagnostic
GB201811382D0 (en) 2018-07-11 2018-08-29 Taylor John Hermon Vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709803D0 (en) 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
US5082767A (en) * 1989-02-27 1992-01-21 Hatfield G Wesley Codon pair utilization
FR2682967B1 (fr) 1991-10-25 1994-01-14 Pasteur Institut Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
WO1994026312A1 (en) * 1993-05-13 1994-11-24 Jacobs William R Jr METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
GB9526178D0 (en) * 1995-12-21 1996-02-21 Taylor John Hermon Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy

Also Published As

Publication number Publication date
WO1997023624A3 (en) 1997-09-12
GB9526178D0 (en) 1996-02-21
DE69634918D1 (de) 2005-08-11
US20040260078A1 (en) 2004-12-23
US20060204521A1 (en) 2006-09-14
DE69634918T2 (de) 2006-05-18
AU735112B2 (en) 2001-06-28
AU1202797A (en) 1997-07-17
US7541181B2 (en) 2009-06-02
WO1997023624A2 (en) 1997-07-03
EP0870032B1 (de) 2005-07-06
US6156322A (en) 2000-12-05
EP0870032A2 (de) 1998-10-14

Similar Documents

Publication Publication Date Title
ATE299182T1 (de) Polynukleotide und polypeptide aus pathogenen mycobakterien und deren verwendung als diagnostika, impfstoffe und als ziel der chemotherapie
EP1439230A3 (de) Menschliche transmembranprotein TMP-2 gen
ATE173505T1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
FR2766193B1 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
NO940736D0 (no) DNA sekvenser som koder for gelonin polypeptid
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
EP0990703A4 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
EP1132402A4 (de) Peptidfragmente mit den zelltod verhindernden aktivität
ATE319819T1 (de) Humane hirn-spezifische carboxypeptidase b
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
EP1023906A4 (de) Verstärker für antikörper gegen lymphoiden tumor
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
TW342413B (en) Novel toxins isolated from Bracon Hebetor
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
TR200003608T2 (tr) Moraxella Catarrhalis'e ait BASB027 proteinleri ve genleri.
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
WO1997026276A3 (en) Vertebrate fringe proteins
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
FI973762A0 (fi) Ny gen
DE69519654D1 (de) htFIIIA Gen
NO940797L (no) Reseptorderivater som har bindingseter for human-rhinovirus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties